Hemostemix Inc. HMTXF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 31.64% | 77.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.49% | -71.41% | |||
| Operating Income | 22.49% | 71.41% | |||
| Income Before Tax | 20.66% | 69.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 20.66% | 69.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.66% | 69.38% | |||
| EBIT | 22.49% | 71.41% | |||
| EBITDA | 22.49% | 71.41% | |||
| EPS Basic | 37.14% | 59.30% | |||
| Normalized Basic EPS | 46.15% | 60.00% | |||
| EPS Diluted | 37.14% | 59.30% | |||
| Normalized Diluted EPS | 46.15% | 60.00% | |||
| Average Basic Shares Outstanding | 25.43% | -24.96% | |||
| Average Diluted Shares Outstanding | 25.43% | -24.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||